Back to Top
Freneslerbart Biosimilar - Research Grade
$710.00 - $19,500.00
Freneslerbart Biosimilar - Research Grade
Endotoxin
≤ 1.0 EU/mg as determined by the LAL method
Purity
>95% by SDS-PAGE
Species Reactivity
Human
Target
Felcat allergen 1
Concentration
5mg/ml
Isotype
Human IgG4 - kappa
Host
CHO Cells
Sequence
https://www.imgt.org/mAb-DB/
Buffer
ICH2834
Shipping Conditions
Blue ice
Background
Fel d 1 (Felcat allergen 1) is the principal cat allergen and a primary antigen in allergy and immunotherapy research. This recombinant anti-Fel-d-1 monoclonal is an unconjugated, non-therapeutic analog of freneslerbart, supplied for research use only (RUO). Manufactured to in vivo standards with low endotoxin, it is offered in scalable milligram (mg) to gram (g) quantities for bulk and high-throughput laboratories. Applications include functional assays, allergen-binding and IgE-blocking studies, reproducible controls, and in vivo models of allergic sensitisation, with the lot-to-lot consistency required for sustained, heavy-usage allergy research.
Specificity
Detects human Felcat allergen 1
Purification Method
This monoclonal antibody was purified using Protein A
Formulation
Sterile, preservative-free, solution in PBS. BSA and Azide free.
Storage
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Applications
Functional Assays
Application Notes
This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.
Use
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Delivery Time
4 weeks
Write Your Own Review













